JavaScript is disabled. Please enable to continue!

Mobile search icon
Pharma Newsletters >> Eurofins Pharma Services Newsletter 11 - June 2015 >> Viracor-IBT Laboratories

Viracor-IBT Laboratories delivers results faster, when it matters most

Sidebar Image

Jenni Miller, Viracor-IBT Laboratories Marketing Manager, jenni.miller@viracoribt.com

A Medical Director of a hospital Bone Marrow Transplant programme recently told a Viracor-IBT Laboratories associate,"Every day Viracor-IBT helps me save lives and helps improve my patient care. We used to send Cytomegalovirus (CMV) [testing] to another lab. It took a few days  to get a result. We switched to Viracor-IBT because they offered one day turnaround time, which is what I needed for my very sick patients.  Since I switched to sending to Viracor-IBT, I have not seen a single case of CMV pneumonitis. It's been years. We have eliminated it. I would say that is lifesaving."

Every day Viracor-IBT helps me save lives and helps improve my patient care

With over 30 years of specialised expertise in infectious disease, immunology and allergy testing for immunocompromised and critical patients, Viracor-IBT is committed to high quality service, helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most. Eurofins acquired Viracor-IBT-one of the largest privately-held, esoteric reference laboratories servicing the specialty diagnostic market-in mid-2014. With industry-leading turnaround times as short as eight to 10 hours from sample receipt to result reporting, Viracor-IBT is focused on helping physicians treat time-sensitive patients. Additionally, pharma companies, biotechs, CROs and central labs rely on Viracor-IBT to transfer, validate and optimise assays addressing studys pecific needs for Phase I through Phase IV clinical trials. Viracor-IBT is based in Lee's Summit, Missouri, with a satellite lab in Los Angeles, California. Its testing capabilities include quantitative and qualitative PCR, DNA sequencing, ELISA and other immunoassay platforms.

The 280+ associates at Viracor-IBT are passionate about delivering value to their clients, never losing sight of the connection between the testing performed and the patients served. This acquisition further demonstrates Eurofins' commitment to serve the emerging needs of the clinicians, pharmaceutical and biotechnology leaders with laboratory services of the highest quality and reliability.

For more information, visit: www.viracoribt.com.